Abstract
The sarafotoxins (SRTXs), a family of peptides isolated from the venom of the snake Atractaspis engaddensis, show striking structural similarities to the endothelins (ETs) produced by endothelial cells. Four isoforms of SRTXs have been identified: SRTX-a, SRTX-b, SRTX-c, and SRTX-e. SRTX-d, which was previously assumed to exist, has not been found (Bdolah et al. 1989b). SRTXe differs from the proposed SRTX-d in having a Gly instead of an Asp in position 18 (Ducancel et al. 1993). These peptides have powerful cardiotoxic effects and cause contraction of smooth muscles. They all contain 21 amino acids and two disulfide bridges, between Cys1-Cys15 and Cys3-Cys11. There is a very high degree of sequence similarity, not only within each family (ETs, 71–95%; SRTXs, 81–95%), but also between families (52–67%) (Kochva et al. 1993). The ETs are produced in minute quantities in mammals (measurable in picomoles per gram of tissue), whereas the SRTXs are produced in large amounts in the venom of the snake (0.1 mmol/g). The SRTXs and ETs may be divided into two groups on the basis of their toxicity. The most lethal are ET1 and SRTX-b; ET-3 is less toxic, and SRTX-c and SRTX-e cause death only at very high doses, if at all. For example, in ICR mice, the LD50 for SRTX-b and ET-1 is 15 μg/kg body weight (Bdolah et al. 1989a). ET-1 and SRTX-b were found to cause severe disturbances in heart function at the level of the A-V conduction system and the coronary vessels, ultimately leading to cartiac arrest.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersen NH, Chen C, Marschner TM, Krystek SR, Bassolino DA (1992) Conformational isomerism of endothelin in acidic aqueous media: a quantitative NOESY analysis. Biochemistry 31:1280–1295
Angelova K, Puett D, Narayan P (1997) Identification of endothelin receptor subtypes in sheep choroid plexus. Endocrine 7:287–293
Arinami T, Ishikawa M, Inoue A, Yanagisawa M, Masaki T, Yoshida MC, Hamaguchi H (1991) Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23-p24, the endothelin-2 gene (EDN2) to lp34, and the endothelin-3 gene (EDN3) to 20q13.2-q13.3. Àm J Hum Genet 48:990–996
Atkins AR, Ralston GB, Smith R. (1994) Conformational stability of the endothelin/sarafotoxin family of peptides. Int J Peptide Protein Res 44:372–377
Atkins AR, Martin RC, Smith R (1995) 1H NMR studies of sarafotoxin SRTb, a nonselective endothelin receptor agonist, and IRL 1620, an ETB receptor-specific agonist. Biochemistry 34:2026–2033
Bdolah A, Wollberg Z, Ambar I, Kloog Y, Sokolovsky M, Kochva E (1989a) Disturbances in the cardiovascular system caused by endothelin and sarafotoxin. Biochem Pharmacol 38:3145–3146
Bdolah A, Wollberg Z, Fleminger G, Kochva E (1989b) SRTX-d, a new native peptide of the endothelin/sarafotoxin family. FEBS Lett 256:1–3
Bdolah A, Wollberg Z, Kochva E (1991) Snake Toxins. In: Harvey L (ed) Pergamon, New York, pp 415–424
Bdolah A, Kochva E, Ovadia M, Kinamon S, Wollberg Z (1997) Resistance of the Egyptian mongoose to sarafotoxins. Toxicon 35:1251–1261
Becker A, Dowdle EB, Hechler U, Kauser K, Donner P, Schleuning WD (1993) Bibrotoxin, a novel member of the endothelin/sarafotoxin peptide family, from the venom of the burrowing asp Atractaspis bibroni. FEBS Lett 315:100–103
Bell KM, Prise VE, Chaplin DJ, Tozer GM (1995) Effect of endothelin-1 and sarafotoxin S6c on blood flow in a rat tumor. J Cardiovasc Pharmacol 26:S222–S225
Bloch KD, Friedrich SP, Lee M-E, Eddy RL, Shows TB, Quertermous T (1989) Structural organization and chromosomal assignment of the gene encoding endothelin. J Biol Chem 264:10851–10857
Bodelsson G, Stjernquist M (1993) Characterization of endothelin receptors and localization of 125I-endothelin-1 binding sites in human umbilical artery. Eur J Pharmacol 249:299–305
Bogoni G, Rizzo A, Calo G, Campobasso C, D’Orleans-Juste P, Regoli D (1996) Characterization of endothelin receptors in the human umbilical artery and vein. Br J Pharmacol 119:1600–1604
Breuiller-Fouche M, Heluy V, Fournier T, Dallot E, Vacher-Lavenu MC, Ferre F (1998) Role of endothelin-1 in regulating proliferation of cultured human uterine smooth muscle cells. Mol Hum Reprod 4:33–39
Calogero AE, Burrello N, Ossino AM (1998) Endothelin (ET)-1 and ET-3 inhibit estrogen and cAMP production by rat granulosa cells in vitro. J Endocrinol 157:209–215
Clozel M, Gray GA, Breu V, Loffler B-M, Osterwalder K (1992) The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 186:867–873
Cristol J-P, Warner T D,Thiemermaan C, Vane JR (1993) Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br J Pharmacol 108:776–779
Davenport AP, Morton AJ, Brown MJ. (1991) Localization of endothelin-1 (ET-1), ET-2, and ET-3, mouse VIC, and sarafotoxin S6b binding sites in mammalian heart and kidney. J Cardiovasc Pharmacol 17:S152–S155
DeNucci G, Thomas R, D’Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JK (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85:9797–9800
Devadason PS, Henry PJ (1997) Comparison of the contractile effects and binding kinetics of endothelin-1 and sarafotoxin S6b in rat isolated renal artery. Br J Pharmacol 121:253–263
Doherty AM, Cody WL, Leitz NL, Depue PL, Taylor MD, Rapundalo ST, Hingorani GP, Major TC, Panek RL, Taylor DG (1991) Structure-activity studies of the C-terminal region of the endothelins and sarafotoxins. J Cardiovasc Pharmacol 17:S59–S61
Docherty C, MacLean MR (1998a) Development of endothelin receptors in perinatal rabbit pulmonary resistance arteries. Br J Pharmacol 124:1165–1174
Docherty C, MacLean MR (1998b) EndothelinB receptors in rabbit pulmonary resistance arteries: effect of left ventricular dysfunction. J Pharmacol Exp Ther 284:895–903
Doi Y, Ozaka T, Katsuki M, Fukushige H, Toyama E, Kanazawa Y, Arashidani K, Fujimoto S (1995) Histamine release from Weibel-Palade bodies of toad aortas induced by endothelin-1 and sarafotoxin-S6b. Anat Rec 242:374–382
Douglas SA, Hiley CR (1991) Endothelium-dependent mesenteric vasorelexant effects and systemic actions of endothelin(16–21) and other endothelin-related peptides in the rat. Br J Pharmacol 104:311–320
Douglas SA, Beck GR Jr, Elliot JD, Ohlstein EH (1995) Pharmacologic evidence for the presence of three functional endothelin receptor subtypes in the rabbit lateral saphenous vein. Br J Pharmacol 114:1529–1540
Ducancel F, Matre U, Dupont C, Lajeunesse E, Wollberg Z, Bdolah A, Kochva E, Boulain JC, Menez A (1993) Cloning and sequence analysis of cDNAs encoding precursors of sarafotoxins. Evidence for an unusual rosary-type organization. J Biol Chem 268:3052–3055
Eglezos A, Cucchi P, Patacchini R, Quartara L, Maggi CA, Mizrahi J (1993) Differential effects of BQ-123 against endothelin-1 and endothelin-3 on the rat vas deferens: evidence for an atypical endothelin receptor. Br J Pharmacol 109:736–738
Elferink JGR, de Koster BM (1996) Modulation of human neutrophil chemotaxis by the endothelin-B receptor agonist sarafotoxin S6c.Chemico-Biol Int 101:165–174
Faro R, Grassikassisse DM, Donato JL, Boin I, Opgenorth TJ, Withrington PG, Zatz R, Antunes E, Denucci G (1995) Role of endothelin ET(A) and ET(B) receptors in the arterial vasculature of the isolated canine liver. J Cardiovasc Pharmacol 26:S204–S207
Galron R, Bdolah A, Kochva E, Wollberg Z, Kloog Y, Sokolovsky M (1991) Kinetic and cross-linking studies indicate different receptors for endothelins and sarafotoxins in the ileum and cerebellum. FEBS Lett 283:11–14
Gardiner SM, Compton AM, Kemp PA, Bennett T (1990) Cardiac output effects of endothelin-1, -2 and -3 and sarafotoxin S6b in conscious rats. J Auton Nerv Syst 30:143–147
Gater PR, Wasserman MA, Renzetti LM (1996) Effects of Ro 47–0203 on endothelin1 and sarafotoxin S6c-induced contractions of human bronchus and guinea-pig trachea. Eur J Pharmacol 304:123–128
Gellai M, De Wolf R, Pullen M, Nambi P (1994) Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive rata. Kidney Int 46:1287–1294
Gellai M, Fletcher T, Pullen M, Nambi P (1996) Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am J Physiol 271:R254–R261
Gulati A, Rebello S (1992) Characteristics of endothelin receptors in the central nervous system of spontaneously hypertensive rats. Neuropharmacology 31: 243–250
Han SP, Knuepfer MM, Trapani AJ, Fok KF, Westfall TC (1990) Cardiac and vascular actions of sarafotoxin S6b and endothelin-1. Life Sci 46:767–775
Harrison VJ, Randriantsoa A, Schoeffter P (1992) Heterogeneity of endothelinsarafotoxin receptors mediating contraction of pig coronary artery. Br J Pharmac 105:511–513
Hay DWP (1992) Pharmacological evidence for distinct endothelin receptors in guinea-pig bronchus and aorta. Br J Pharmacol 106:759–761
Hay DWP, Luttmann MA (1997) Nonpeptide endothelin receptor antagonists. IX. Characterization of endothelin receptors in guinea-pig bronchus with SB 209670 and other endothelin receptor antagonists. J Pharmacol Exp Ther 280:959–965
Hay DWP, Luttmann MA, Beck G, Ohlstein EH (1996) Comparison of endothelinB (ETB) receptors in rabbit isolated pulmonary artery and bronchus. Br J Pharmacol 118:1209–1217
Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA. 86: 2863–2867
Ishikawa H, Haruno I, Harada Y, Yoshitomi T, Ishikawa S, Katori M (1996) Pharmacological characterization of endothelin receptors in the rabbit iris sphincter muscle: suggestion for the presence of atypical receptors. Curr Eye Res 15:73–78
Iwasaki T, Notoya M, Hayasaki-Kajiwara Y, Shimamura T, Naya N, Ninomiya M, Nakajima M (1999) Endothelium-independent vascular relaxation mediating ETB receptor in rabbit mesenteric arteries. Am J Physiol 276:H383–390
Johns CR, Hiley CR (1990) Heterogeneity of [125I]sarafotoxin S6b binding in rat tissues. Eur J Pharmacol 183:1746
Kitazumi K, Shiba T, Nishiki K, Furukawa Y, Takasaki C, Tasaka K. (1990) Structure-activity relationship in vasoconstrictor effects of sarafotoxins and endothelin-1. FEBS Lett 260:269–272
Kloog Y, Ambar I, Sokolovsky M, Kochva E, Bdolah A, Wollberg Z (1988) Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science 242:268–270
Kochva E, Bdolah A, Wollberg Z. (1993) Sarafotoxins and endothelins: evolution, structure and function. Toxicon 31:541–568
Koshi T, Suzuki C, Arai K, Mizoguchi T, Torii T, Hirata M, Ohkuchi M, Okabe T (1991) Syntheses and biological activities of endothelin-1 analogs. Chem Pharm Bull 39:3061–3063
Kumar A, Shahani BT, Gulati A (1996) Modification of systemic and regional circulatory effects of intracerebroventricular administration of endothelin-1 (ET-1) by propranolol in anesthetized rats. Gen Pharmacol 27:1025–1033
Kumar A, Morrison S, Gulati A (1997) Effect of ETA receptor antagonists on cardiovascular responses induced by centrally administered sarafotoxin 6b: role of sympathetic nervous system. Peptides 18:855–864.
Lamthanh H, Bdolah A, Creminon C, Grassi J, Menez A, Wollberg Z, Kochva E (1994) Biological activities of [Thr2]sarafotoxin-b, a synthetic analogue of sarafotoxin-b. Toxicon 32:1105–1114
Landan G, Bdolah A, Wollberg Z, Kochva E, Graur D (1991a) Evolution of the sarafotoxin/endothelin superfamily of proteins. Toxicon 29:237–244
Landan G, Bdolah A, Wollberg Z, Kochva E, Graur D (1991b) The evolutionary history of the sarafotoxin/endothelin/endothelin-like superfamily J Cardiovasc Pharmacol 17:S517–S519
Laursen M, Bodelsson G, Stjernquist M (1998) Atypical receptors mediate the response to endothelin-1 and sarafotoxin S6b in the human umbilical artery. Eur J Pharmacol 362:167–172
Lecoin L, Sakurai T, Ngo M-T, Abe Y, Yanagisawa M, Le Douarin NM (1998) Cloning and characterization of a novel endothelin receptor subtype in the avian class. Proc Natl Acad Sci USA 95:3024–3029
Leis HJ, Zach D, Huber E, Windischhofer W (1998) Prostaglandin endoperoxide synthase-2 contributes to the endothelin/sarafotoxin-induced prostaglandin E2 synthesis in mouse osteoblastic cells (MC3T3-E1): evidence for a protein tyrosine kinase-signaling pathway and involvement of protein kinase C. Endocrinology 139:1268–1277
Lin WW, Chen YM, Lee SY, Nishio H, Kimura T, Sakakibara S, Lee CY (1990) Cardiovascular effects of two disulfide analogues of sarafotoxin S6b. Toxicon 28:911–923
Luciano LG, D’Orleans-Juste P, Calixto JB, Rae GA (1998) Endothelin-1 selectively potentiates the purinergic component of sympathetic neurotransmission in rat seminal vesicle. J Cardiovasc Pharmacol 31:S515–S517
MacLean MR, Mackenzie JF, Docherty CC (1998) Heterogeneity of endothelin-B receptors in rabbit pulmonary resistance arteries. J Cardiovasc Pharmacol 31:S115–S118
Maguire JJ, Kuc RE, Rous BA, Davenport AP (1996) Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments. Br J Pharmacol 118:335–342
Matsuda H, Kawaguchi A, Uematsu M, Ohmori F, Nagata S, Miyatake K (1996) Endothelins contract guinea-pig pulmonary artery and enhance its adrenergic response via ETA receptors. Clin Exp Pharmacol Physiol 23:379–385
McCulloch KM, Docherty C, MacLean MR (1998) Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat. Br J Pharmacol 123:1621–1630
Miasiro N, Karaki H, Paiva (1998) Distinct endothelin-B receptors mediate the effects of sarafotoxin S6c and IRL1620 in the ileum. J Cardiovasc Pharmacol 31:S175–S178
Miller V, Michener SR (1995) Modulation of contractions to and receptors for endothelins in canine veins. Am J Physiol 268:H345–H350
Mills, RG, Ralston, GB, King GF (1994) The solution structure of sarafotoxin-c. J Biol Chem 269:23413–23419
Mondon F, Maka F, Sabry S, Ferre F (1995) Endothelin-induced phosphoinositide hydrolysis in the muscular layer of stem villi vessels of human term placenta. Eur J Endocrinol 133:606–612
Moreland S, McMullen D, Abboa-Offei B, Seymour A (1994) Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature. Br J Pharmacol 112:704–708
Mutafova-Yambolieva VN, Westfall DP (1998) Inhibitory and facilitatory presynaptic effects of endothelin on sympathetic cotransmission in the rat isolated tail artery. Br J Pharmacol 123:136–142
Nambi P, Wu H-L, Pullen M, Aiyar N, Bryan D, Elliott J (1992) Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands. Mol Pharmacol 42:336–339
Nambi P, Pullen M, Kumar C (1994) Identification of a novel endothelin receptor in Xenopus laevis liver. Neuropeptides 26:181–185
Nambi P, Pullen M, Brooks DP, Gellai M (1995) Identification of ETB receptor subtypes using linear and truncated analogs of ET. Neuropeptides 29:331–336
Nishiyama M, Takahara Y, Masaki T, Nakajima N, Kimura S (1995) Pharmacological heterogeneity of both endothelin ETA- and ETB-receptors in the human saphenous vein. Jpn J Pharmacol 69:391–398
Nosaka C, Ishikawa H, Haruno I, Yoshitomi T, Kase H, Ishikawa S, Harada Y (1998) Radioligand binding characteristics of the endothelin receptor in the rabbit iris. Jpn J Pharmacol 76:289–296
Opgenorth TH, Wu-Wong JR, Shiosaki K (1992) Endothelin-converting enzymes. FASEB J 6:2653–2659
Panek RL, Major TC, Hingorani GP, Doherty AMA, Taylor DG (1992) Endothelin and structurally related analogs distinguish between endothelin receptor subtypes. Biochem Biophys Res Commun 183:566–571
Pate MA, Chester AH, Brown TJ, Roach AG, Yacoub MH (1998) Atypical antagonism observed with BQ-123 in human saphenous vein. J Cardiovasc Pharmacol 31:S172–S174
Poulat P, De Champlain J, D’Orleans-Juste P, Couture R (1996) Receptor and mechanism that mediate endothelin- and big endothelin-1-induced phosphoinositide hydrolysis in the rat spinal cord. Eur J Pharmacol 315:327–334
Rasmussen TE, Jougasaki M, Supaporn T, Hallett JW Jr, Brooks DP, Burnett JC Jr (1998) Cardiovascular actions of ET-B activation in vivo and modulation by receptor antagonism. Am J Physiol 274:R131-R138
Rebello S, Roy S, Saxena PR, Gulati A (1995) Systemic hemodynamic and regional circulatory effects of centrally administered endothelin-1 are mediated though ETA receptors. Brain Res 676:141–150
Rose PM, Krystek SR Jr, Patel PS, Liu ECK, Lynch JS, Lach DA, Fisher SM, Webb ML (1995) Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors. FEBS Lett 361:243–249
Russell FD, Davenport AP (1996) Characterization of the binding of endothelin ETB selective ligands in human and rat heart. Br J Pharmacol 119:631–636
Servitja JM, Masgrau R, Sarri E, Picatoste F (1998) Involvement of ET(A) and ET(B) receptors in the activation of phospholipase D by endothelins in cultured rat cortical astrocytes. Br J Pharmacol 124:1728–1734
Shannon TR, Hale CC (1994) Identification of a 65 kDa endothelin receptor in bovine cardiac sarcolemmal vesicles. Eur J Pharmacol 267:233–238
Shraga-Levine Z, Galron R, Sokolovsky M (1994) Cyclic GMP formation in rat cerebellar slices is stimulated by endothelins via nitric oxide formation and by sarafotoxins via formation of carbon monoxide. Biochemistry 33:14656–14659
Shraga-Levine Z, Sokolovsky M (1996) cGMP formation in rat atrial slices is ligand and endothelin receptor subtype specific. Circ Res 78:424–430
Shraga-Levine Z, Sokolovsky M (2000) Functional Coupling of G Proteins to Endothelin Receptors Is Ligand and Receptor Subtype Specific. Cellular and Molecular Neurobiology 20:305–317
Sokolovsky M (1995) Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. Pharmacol Ther 68:435–471
Sokolovsky M, Galron R, Kloog Y, Bdolah A, Indig FE, Blumberg S, Fleminger G (1990) Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc Natl Acad Sci USA 87:4702–4706
Sokolovsky M, Shraga-Levine Z, Galron R (1994) Ligand-specific stimulation/inhibition of cAMP formation by a novel endothelin receptor subtype. Biochemistry 33:11417–11419
Sudhir K, Ko E, Zellner C, Wong HE, Hutchison SJ, Chou TM, Chatterjee K (1997) Physiological concentrations of estradiol attenuate endothelin 1- induced coronary vasoconstriction in vivo. Circulation 96:3626–3632
Sudjarwo SA, Hori M, Tanaka M, Matsuda T, Okada T, Karaki H (1994) Subtypes of endothelin ETA and ETB receptors mediating venous smooth muscle contraction. Biochem Biophys Res Commun 200:627–633
Takasaki C, Aimoto S, Kitazumi K, Tasaka K, Shiba T, Nishiki K, Furukawa Y, Takayanagi R, Ohnaka K, Nawata H (1991) Structure-activity relationships of sarafotoxins: chemical syntheses of chimera peptides of sarafotoxins S6b and S6c. Eur J Pharmacol 198:165–169
Tamaoki H, Kyogoku Y, Nakajima K, Sakakibara S, Hayashi M, Kobayashi Y (1992) Conformational study of endothelins and sarafotoxins with the cystine-stabilized helical motif by means of CD spectra. Biopolymers 32:353–357
Tanaka T, Ogawa T, Matsuda Y. (1995) Species differences in the binding characteristics of RES-701–1: a potent endothelin ETB receptor-selective antagonist. Biochem Biophys Res Commun 209:712–716
Uchida K, Yuzuki R, Kamikawa Y (1998) The role of receptor-operated Ca2+ influx in endothelin-induced contraction of the muscularis mucosae. J Cardiovasc Pharmacol 31:S504–S506
Warner TD, Allcock GK, Corder R, Vane JR (1993a) Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol 110:777–782
Warner TD, Allcock GK, Mickley EJ, Corder R, Vane JR (1993b) Comparative studies with the endothelin receptor antagonists BQ-123 and PD 142893 indicate at least three endothelin receptors J Cardiovasc Pharmacol 22:S117–S120
White DG, Garrat H, Mundin JW, Sumner MJ, Vallance PJ, Watts IS (1994) Human saphenous vein contains both endothelin ETA and ETB contractile receptors. Eur J Pharmacol 257:307–310
Williams DL, Jones KL, Pettibone DJ, Lis EV, Clinschmidt BV (1991) Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175:556–661
Yoneyama T, Hori M, Tanaka T, Matsuda Y, Karaki H (1995) Endothelin ETA and ETB receptors facilitating parasympathetic neurotransmission in the rabbit trachea. J Pharmacol Exp Therap 275:1084–1089
Zuccarello M, Boccaletti R, Rapoport RM (1998a) Endothelin ETB receptor-mediated constriction in the rabbit basilar artery. Eur J Pharmacol 350:R7-R9
Zuccarello M, Boccaletti R, Rapoport RM (1998b) Endothelin ETB receptormediated relaxation of rabbit basilar artery. Eur J Pharmacol 357:67–71
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sokolovsky, M., Shraga-Levine, Z. (2001). Sarafotoxins and Their Relationship to the Endothelin Family of Peptides. In: Warner, T.D. (eds) Endothelin and Its Inhibitors. Handbook of Experimental Pharmacology, vol 152. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56899-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-56899-2_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63237-2
Online ISBN: 978-3-642-56899-2
eBook Packages: Springer Book Archive